Immune response to threecycles of MVA-EBNA1/LMP2 vaccine, Occurrence of adverse events definedaccording to NCI CTCAE version 4.02, Immune memory, and recall responseto MVA-EBNA1/LMP2 vaccination, Measurement of EBV genome levels inplasma before, during and after vaccination, Tumor response as determinedby Immune-Related Response Criteria (irRC). The gene discussed is PSMB9; the disease is neoplasm.